Culpeper Star-Exponent: 7th District Residents Respond to $35 a Month Cap on Insulin Costs

CULPEPER STAR-EXPONENT

Seventh District residents are enjoying this summer’s new $35 per month cap on out-of-pocket insulin costs, according to Rep. Abigail Spanberger, D-7th.

In a July release, she shared stories received through a survey conducted to get feedback on how Virginia seniors have been affected by the new limit.

“I am a type two diabetic. My insulin costs monthly are running around $50 per month — now I’m only paying $35! Thank you Congresswoman Spanberger!” said George Lewis of Orange County in the survey.

The $35 per month cap on out-of-pocket costs for insulin covered under Medicare Part B went into effect on July 1, signed into law as part of the Inflation Reduction Act supported by the local congresswoman. The monthly cap for insulin covered under Part D went into effect Jan. 1.

“I have a friend that asked me to seek financial assistance for medication expenses. Before I could put pen to paper, the assistance brought relief to her. Elders suffer more so than any others. Keep up the great work. The help is needed beyond comprehension. God bless,” wrote John Fortune of Spotsylvania County in Spanberger’s survey.

Even before elected to Congress in 2018, the congresswoman said she heard from Virginia seniors and their loved ones about the burden the skyrocketing cost of needed medicine places on some of the most vulnerable neighbors.

“These Virginians deserve real, tangible solutions to make these medications more accessible,” said Spanberger. “And as a member of Congress serving thousands of seniors who rely on the drug, I want to know whether this change has made an impact in their lives.”

An estimated 6,600 Medicare beneficiaries receive insulin in Virginia’s 7th District, according to Spanberger.

According to the U.S. House Committee on Oversight and Reform, the cap will save a senior in the district enrolled in a standard Medicare drug plan who used Novolog — one of the most commonly-prescribed rapid-acting insulins — more than $1,500 per year.

Recent Posts


Jun 14, 2024
Press

Spanberger Statement on Supreme Court Ruling to Strike Down Federal Bump Stock Ban

Congresswoman: “As a Former Federal Law Enforcement Officer, I Know that Weapons Designed to Inflict Maximum Casualties Do Not Belong on Our Streets, in Our Schools, or in Our Communities” WASHINGTON, D.C. — U.S. Representative Abigail Spanberger today released the following statement following the U.S. Supreme Court’s decision in Garland v. Cargill, which overturns a […]



Jun 14, 2024
Gun Safety

During National Gun Violence Awareness Month, Spanberger Urges Speaker Johnson to Bring Bipartisan Bills to U.S. House Floor to Prevent Gun Violence

Congresswoman: “I Used To Carry A Gun Every Single Day — I Know What It Is To Be A Responsible Gun Owner” WASHINGTON, D.C. — On the floor of the U.S. House of Representatives, U.S. Representative Abigail Spanberger — a Member of the U.S. House Gun Violence Prevention Task Force — urged Speaker Johnson to […]



Jun 13, 2024
Womens' Issues

Spanberger Statement on Supreme Court Ruling to Protect Mifepristone Access

Congresswoman: “We Should Never Have Come This Close to the Fundamental Freedoms of Women in Virginia and Across the Country Being Stripped Away” WASHINGTON, D.C. — U.S. Representative Abigail Spanberger today released the following statement after the U.S. Supreme Court’s ruling to uphold access to mifepristone. “Since the Supreme Court overturned Roe v. Wade nearly […]